Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring

Inflammatory bowel disease (IBD) is a chronic condition that significantly affects the quality of life of its patients. Biologic drugs have been the mainstay treatment in the management of IBD patients but despite their significant contribution, there remains a proportion of patients that do not res...

Descripción completa

Detalles Bibliográficos
Autores principales: Albader, Farah, Golovics, Petra Anna, Gonczi, Lorant, Bessissow, Talat, Afif, Waqqas, Lakatos, Peter Laszlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515794/
https://www.ncbi.nlm.nih.gov/pubmed/34712029
http://dx.doi.org/10.3748/wjg.v27.i37.6231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515794/
https://www.ncbi.nlm.nih.gov/pubmed/34712029
http://dx.doi.org/10.3748/wjg.v27.i37.6231

Ejemplares similares